Beta Bionics Chief Commercial Officer Mark Hopman sells $16,420 in common shares
BBNX•Beta Bionics Chief Commercial Officer Mark Hopman sold 821 shares at $20 each on October 26, 2026, leaving him with 54,513 shares held directly.
1. Share sale
Mark Hopman sold 821 shares of Beta Bionics common stock at $20 each on October 26, 2026. The transaction left him with 54,513 shares held directly.
